Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2022-01-14 Declaration of Voting R…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document details a change in shareholding and voting rights for a specific holder (Invesco Ltd.) in an issuer (Biotage AB). It explicitly shows 'Before the transaction' and 'After the transaction' figures for shares and voting rights, crossing a threshold (5%). This structure is characteristic of mandatory notifications regarding significant changes in ownership interests. Among the provided definitions, 'Major Shareholding Notification' (MRQ) fits this description best, as it covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an Annual Report (10-K), Earnings Release (ER), or a general regulatory filing (RNS), but a specific disclosure about ownership.
2022-01-14 English
Change in number of shares and votes
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Biotage AB dated December 30, 2021, titled "Change in number of shares and votes." It explicitly details the issuance of new class C shares (243,252) resulting from an incentive program adopted at the AGM, and updates the total number of outstanding shares and votes. This content directly relates to changes in the company's capital structure due to share issuance, which aligns with the definition of 'Share Issue/Capital Change' (SHA). Although it mentions the AGM, the core subject is the resulting share count change, not the meeting itself or a proxy solicitation. It is not a full financial report (10-K or IR) nor a general regulatory filing (RNS), but a specific announcement about capital structure modification.
2021-12-30 English
Förändring i antal aktier och röster
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated December 30, 2021, titled "Förändring i antal aktier och röster" (Change in number of shares and votes). It explicitly details the increase in the total number of outstanding shares (C-shares issued under an incentive program) and the resulting change in the total number of votes and share capital as of the last trading day of the month. This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). Although it is a press release, the core subject matter is a capital change, making SHA more specific than a general RPA or RNS.
2021-12-30 Swedish
Ny sammansättning av Biotage valberedning
AGM Information Classification · 95% confidence The document is a press release from Biotage AB dated December 13, 2021, announcing a 'Ny sammansättning av Biotage valberedning' (New composition of the Biotage Nomination Committee). The text details the members appointed to the nomination committee, whose task is to prepare for the 2022 Annual General Meeting (AGM), including the election of board members and remuneration issues. This content directly relates to the governance and preparation for shareholder meetings, specifically concerning board nominations. This aligns best with 'Board/Management Information' (MANG) as it concerns the composition of a committee responsible for board nominations, or potentially 'Governance Information' (CGR). However, since it is a specific announcement about the composition of the body responsible for nominating directors, MANG is a strong fit. It is not a full AGM presentation (AGM-R), a proxy statement (PSI), or a general regulatory filing (RNS). Given the focus on the composition of the body that selects board members, MANG is the most precise fit among the options provided.
2021-12-13 Swedish
New composition of Biotage Nomination Committee
AGM Information Classification · 95% confidence The document is a press release dated December 13, 2021, announcing the 'New composition of Biotage Nomination Committee'. The Nomination Committee's purpose is explicitly stated: to prepare proposals for the election of the Board of Directors, Chairman, Auditors, and fees for the upcoming 'Annual General Meeting 2022'. This announcement directly relates to the governance and preparatory steps for the Annual General Meeting (AGM). While it is not the AGM presentation itself (AGM-R) or the proxy materials (PSI), it is a specific announcement concerning the governance structure leading up to the AGM. Given the options, this type of announcement regarding the composition of the committee responsible for AGM proposals is most closely related to general governance or AGM preparation. Since there is no specific code for 'Nomination Committee Announcement', and it deals with board/governance structure leading to the AGM, it fits best under Governance Information (CGR) or potentially AGM Information (AGM-R) if interpreted broadly as AGM-related material. However, the core content is about the composition of a governance body (Nomination Committee) which is a key aspect of corporate governance. I will classify it as Governance Information (CGR) as it details the structure and members of a key governance body, which is a better fit than AGM-R (which implies the meeting materials themselves).
2021-12-13 English
Director's Dealing 2021
Director's Dealing Classification · 98% confidence The document details a change in shareholding and voting rights for a specific holder (ODIN Forvaltning AS) in the issuer (Biotage AB). It explicitly shows the 'Before the transaction' and 'After the transaction' quantities and percentages of shares and voting rights. This type of filing, reporting changes in significant share ownership that cross certain thresholds (implied by the structure, even if the threshold itself is mentioned as 5%), aligns directly with the definition of a Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a director's dealing (DIRS), as it concerns an external holder's stake.
2021-12-02 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.